Newmont Mining Corp. (NEM) Financials Nov 18, 2014, 7:54
Newmont Mining Corp. (NEM) Financials Nov 18, 2014, 7:54 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Newmont Mining Corp.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 7.53B 9.38B 10.42B 9.84B 8.35B
Cost of Goods Sold (COGS) incl. D&A 4.06B 4.79B 5.53B 5.85B 6.97B
COGS excluding D&A 3.22B 3.8B 4.44B 4.77B 5.54B
Depreciation & Amortization Expense 840M 989M 1.09B 1.09B 1.43B
Depreciation 34M 44M 50M 55M 70M
Amortization of Intangibles 806M 945M 1.04B 1.03B 1.36B
Gross Income 3.47B 4.59B 4.89B 3.99B 1.38B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 288M 394M 571M 560M 425M
Research & Development 135M 216M 373M 348M 222M
Other SG&A 153M 178M 198M 212M 203M
Other Operating Expense 251M 255M 214M 379M 206M
Unusual Expense (62M) (158M) 2.37B 153M 4.56B
EBIT after Unusual Expense 62M 158M (2.37B) (153M) (4.56B)
Non Operating Income/Expense 23M 136M 342M 444M 463M
Non-Operating Interest Income 42M 66M 45M 54M 48M
Equity in Affiliates (Pretax) - - - - -
Interest Expense 148M 306M 311M 280M 284M
Gross Interest Expense 259M 327M 363M 387M 372M
Interest Capitalized 111M 21M 52M 107M 88M
Pretax Income 2.91B 4B 1.81B 3.11B (3.59B)
Income Tax 788M 856M 713M 869M (813M)
Income Tax - Current Domestic 5M 214M 346M 210M 129M
Income Tax - Current Foreign 782M 1.02B 1.04B 644M 372M
Income Tax - Deferred Domestic (42M) (518M) (185M) (107M) (869M)
Income Tax - Deferred Foreign 43M 138M (486M) 122M (445M)
Income Tax Credits - - - - -
Equity in Affiliates (16M) 3M 11M (51M) (5M)
Other After Tax Income (Expense) (5M) 0 0 0 0
Consolidated Net Income 2.1B 3.14B 1.11B 2.19B (2.78B)
Minority Interest Expense 796M 839M 606M 309M (254M)
Net Income 1.31B 2.31B 502M 1.89B (2.52B)
Extraordinaries & Discontinued Operations (11M) (28M) (136M) (76M) 61M
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations (11M) (28M) (136M) (76M) 61M
Net Income After Extraordinaries 1.3B 2.28B 366M 1.81B (2.46B)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 1.31B 2.31B 502M 1.89B (2.52B)
EPS (Basic) 2.66 4.63 0.74 3.65 (4.94)
Basic Shares Outstanding 487M 492M 494M 496M 498M
EPS (Diluted) 2.66 4.55 0.73 3.63 (4.94)
Diluted Shares Outstanding 487M 500M 504M 499M 498M
EBITDA 3.77B 4.93B 5.19B 4.14B 2.18B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Bybit Plays the Game of Expansion Step right up to Bybit’s latest offering – ByPick Season 2. Some folks might be scratching their heads about what's shifting in this free-to-play space, but here we are, watching a beast that’s a mix between a carnival game and a hedge fund playpen. No money exchanged, just knowledge on the line. That's right, we're diving into a...
Continue Reading
Cementing Long-Term Trust in Tartu Apartments When you're talking about real estate, especially with high groundwater levels, a solid foundation isn't just a metaphor—it's a lifeline. The 18-unit Saekoja 5 project in Tartu, Estonia, recognized this from the get-go, deciding to put PENETRON ADMIX SB through its paces for the elevator pits and foundation slab. Near the...
Continue Reading
PSE&G Climbs To Number One Spot: What's Changed? Public Service Electric & Gas (PSE&G), New Jersey's largest utility, just snagged the top spot for business electric customer satisfaction in the East, according to JD Power's latest study. This is an upgrade from their second place showing in 2025. But how did they leapfrog their competition to reach the pinnacle? The...
Continue Reading
Trouble at Endava: Leadership Shakeup and Financial Concerns So, here's the kicker—Endava's got itself into one mighty mess worth chewing over with your morning coffee. When your top brass drops like flies, and you're fumbling your financials, investors start sweating bullets. On October 28, 2026, Endava plc (NYSE: DAVA) confesses to some serious accounting missteps....
Continue Reading
TCL Electronics: Riding High on Strategic Moves Buckle up, because TCL Electronics has popped the hood and revealed quite the engine for growth. In the first three quarters of 2026, they cranked their adjusted profit up by a whopping 54.5%, hitting HK$2.24 billion. It's a hefty lift that would make any investor sit up and take notice. What's pushing this upswing? A...
Continue Reading
Longsys and Lexar: A Revolution in Storage Ah, the tech world—it's like a fast-moving express train you just can't afford to miss. Longsys and its sidekick Lexar are in the spotlight this time, and boy, they've got some head-turning announcements. At electronica 2026 in Munich, they're playing the storage game hard. From industrial-grade mSSD to automotive solutions,...
Continue Reading
Betting Big on Small Business If you've ever run a small business, you know it can feel like a hamster wheel—more customers usually mean more headaches. But here comes Worker.ai, stepping onto the scene with big promises and a fancy new acquisition. They've scooped up DeltaGen—a mover in real-time AI tech—and launched a platform to hand these overworked owners a...
Continue Reading
A Personal Mission Driving Business in Hollywood Dive deep into any community, and you'll often find stories that tug at the heartstrings—especially when they're about family. That's the case with Saudia Sital, a Broward County local who's just opened Always Best Care Senior Services in Hollywood, Florida. Her journey from personal caregiver to business owner isn't just...
Continue Reading
Holographics in Home Security: A Game Changer? Pittsburgh isn't exactly the Silicon Valley, but it seems like InventHelp's latest brainchild, the HOLOSECURE HUB, may bring a slice of futuristic tech to our living rooms. Crafted by a forward-thinking mind out of Indianapolis, this gizmo promises to blend the flashy, sci-fi allure of holographics with practical AI-driven...
Continue Reading
A New Chapter for CSTS and Sustainability Leadership Who would've thunk it? CSTS Enterprises, primarily known for its integrated media and sports ventures, is stepping into the sustainability arena as the Official Hospitality Partner for the Nobel Sustainability Trust Hong Kong Summit 2026. They're not just dipping a toe—they're diving headfirst into the pool, bringing...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding the Recent Developments in IMF Talks with Argentina The International Monetary Fund (IMF) is currently navigating a complicated landscape in its negotiations with Argentina, showcasing the ever-evolving nature of international finance and politics. Recently, Rodrigo Valdes, the IMF director for the Western Hemisphere, has officially assigned all negotiation...
Continue Reading
IO Biotech Unveils Breakthrough Pre-Clinical Data for Cancer Vaccines IO Biotech, a clinical-stage biopharmaceutical company listed on the Nasdaq under the ticker IOBT, is at the forefront of developing immune-modulatory, off-the-shelf therapeutic cancer vaccines. Recently, the company revealed exciting data highlighting its two promising candidates: IO112 and IO170, both...
Continue Reading
October Marijuana Stock Performance Overview The marijuana stock market has shown a diverse range of movements this October. Investors and enthusiasts remain eager to analyze these trends as companies navigate the ever-changing landscape of the cannabis industry. This article provides insights into the key movers within this sector, identifying both the top performers and...
Continue Reading
Compliance in the Fast Lane The compliance world just got a hefty upgrade with EQS Group's latest rollout: 'Q by EQS,' an AI-powered intelligence layer that's here to shake up the way compliance tasks are handled. It's integrated right into the heart of the EQS Compliance Cockpit, giving teams an edge by automating those pesky, time-sucking routines and guiding them...
Continue Reading
Olema Oncology to Present at Major Healthcare Event Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a dynamic clinical-stage biopharmaceutical company focused on developing targeted therapies for breast cancer and related conditions, is all set to present its innovative findings at the renowned J.P. Morgan Healthcare Conference. This key...
Continue Reading